Preparing independent, creative leaders in the pharmaceutical sciences and in the application of genetics and genomics to the development of safe, effective drugs for patients
Results from the largest single study of the genetic and environmental causes of asthma in African American children suggest that only a tiny fraction of known genetic risk factors for the disease apply to this population.
School faculty member Esteban G. Burchard, MD, MPH, has been appointed to an expert panel advising the National Institutes of Health (NIH) on how to develop President Barack Obama’s Precision Medicine Initiative.
In the largest study of its kind to date, researchers led by UCSF scientists found that infants in minority populations who are exposed to motor vehicle air pollution, specifically nitrogen dioxide (NO2), are more likely to develop asthma later in childhood.
Genetic ancestry can tell more about a person's potential lung function than the self-identified racial profile commonly used to determine normal lung function reference standards, according to the results of research led by UCSF and Northwestern University.
Asthma specialist and genetics researcher, Esteban G. Burchard, MD, MPH, joint faculty member in the UCSF Schools of Pharmacy and Medicine, discusses the differences in the incidence of asthma and response to asthma drugs among various subgroups within the larger Latino population.
While tailoring medications to a group's genetic ancestry can be important, scientists warn that these generalizations might also be misleading. UCSF School of Pharmacy faculty member and pharmacogenetics and asthma researcher Esteban Burchard, MD, comments at the Genomics, Race, and Health...